Drug development: Illuminated targets

Megan Cully
Additional contact information
Megan Cully: Megan Cully is a freelance writer based in London, UK.

Nature, 2014, vol. 511, issue 7508, S12-S13

Abstract: The development of effective antiepilepsy drugs is moving on from trial-and-error approaches to sophisticated molecular solutions.

Date: 2014
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/511S12a Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:511:y:2014:i:7508:d:10.1038_511s12a

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/511S12a

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().